2015 Pediatric Pharmacology Bundle ** SAVE**

Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits, as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations.
Current MedWatch Safety Alerts issued by the FDA will also be covered.

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.

Both members and non-members SAVE by purchasing as a bundle. Here are all six courses listed below:
2015 Pediatric Rx, Module 1 - What's New in Pediatric Pharmacology.
2015 Pediatric Rx, Module 2 - Respiratory Drugs.
2015 Pediatric Rx, Module 3 - Psychotropic Medications for Children and Adolescents.
2015 Pediatric Rx, Module 4 - GI Drugs Update.
2015 Pediatric Rx, Module 5 - How High do They Look? Identification and Treatment of Common Ingestions in Adolescents and Young Adults.
2015 Pediatric Rx, Module 6 - Nutraceuticals and Supplement Use in Children  

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright 2015 © by National Association of Pediatric Nurse Practitioners (NAPNAP)

Target Audience

Pediatric-focused advanced practice registered nurses


Course summary
Course opens: 
Course expires: 

Teri Moser Woo, PhD, CPNP, CNL, FAANP, Associate Dean for Graduate Nursing Programs, Pacific Lutheran University, Tacoma, Wash.; Woodcreek Pediatrics, Puyallup, Wash.


Dr. Moser Woo has no financial relationships with any commercial entities to disclose, and will not discuss off label use and/or investigational use of individual drugs in this presentation.


Please login or register to take this course.